Cargando…
The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders
Whole genome sequencing (WGS) has the potential to be a comprehensive genetic test, especially relevant for individuals with neurodevelopmental disorders, syndromes and congenital malformations. However, the cost consequences of using whole genome sequencing as a first-line genetic test for these in...
Autores principales: | Runheim, Hannes, Pettersson, Maria, Hammarsjö, Anna, Nordgren, Ann, Henriksson, Martin, Lindstrand, Anna, Levin, Lars-Åke, Soller, Maria Johansson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140052/ https://www.ncbi.nlm.nih.gov/pubmed/37106068 http://dx.doi.org/10.1038/s41598-023-33787-8 |
Ejemplares similares
-
Societal costs associated with pulmonary arterial hypertension: A study utilizing linked national registries
por: Runheim, Hannes, et al.
Publicado: (2023) -
Societal costs associated to chronic thromboembolic pulmonary hypertension: A study utilizing linked national registries
por: Kjellström, Barbro, et al.
Publicado: (2023) -
From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability
por: Lindstrand, Anna, et al.
Publicado: (2019) -
Zebrafish Models of Neurodevelopmental Disorders: Limitations and Benefits of Current Tools and Techniques
por: Vaz, Raquel, et al.
Publicado: (2019) -
Whole genome sequencing unveils genetic heterogeneity in optic nerve hypoplasia
por: Dahl, Sara, et al.
Publicado: (2020)